Scoring vs Knights
31 points above his season average of 31.
Recent Form vs This Matchup
Last 5 at 40, 22 below his 62 average against them.
Game Time vs Knights
Averages 80 minutes a game against the Knights, compared with 78 across the season.
Recent Meetings
Points Avg.
37.0 (last 3 rnd) vs. 40.2 (last 5 rnd)
vs. Break Even
Avg. 30.7 – 1 pts above BE (30)
Price Activity
-$74k (season)
Avg. Minutes Played
80 mins (last 3 rnd) vs. 80 (last 5 rnd)
Player of Difference (POD)
Owned by 1.3% of teams
Captaincy Ceiling
70+ scores – 0% of games
Showing 21 of 46 games
Josiah Karapani is averaging 31 fantasy points from 16 games for the Brisbane Broncos this season. His top score for the year is 62 and he scored 29 in his most recent game.
Over his last three games he has averaged 37, playing an average of 80 minutes. Across the season he has scored 6 tries and is averaging 5 tackles and 159 run metres a game.
Karapani's break even is 30, at a current price of $431k. A break even is the score a player needs to reach for his price to hold. Scores above it push the price up and scores below it pull the price down.
He has averaged 37 over his last three games, so on current form he is clearing that mark and his price should keep climbing.
Karapani has averaged 37 over his last three games, above his break even of 30. That points to price rises in the coming rounds, which is the window coaches look for when trading a player in.
The charts above show his full price, score and break even history for the season, and the game log breaks down where his points are coming from.
Karapani is priced at $431k in NRL Fantasy. His starting price this season was $505k and he has fallen $74k since.
Players at that price are usually picked for price growth, and with his recent scores clearing his break even his price is still climbing. He is currently owned by 1% of NRL Fantasy teams.
Karapani and the Brisbane Broncos next face the Newcastle Knights in Round 22.
After that the Brisbane Broncos have the Dolphins and then the New Zealand Warriors.